BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35779527)

  • 1. Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patients.
    Burnett CE; Okholm TLH; Tenvooren I; Marquez DM; Tamaki S; Munoz Sandoval P; Willmore A; ; Hendrickson CM; Kangelaris KN; Langelier CR; Krummel MF; Woodruff PG; Calfee CS; Erle DJ; Ansel KM; Spitzer MH
    Immunity; 2022 Jul; 55(7):1284-1298.e3. PubMed ID: 35779527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conserved immune trajectory of recovery in hospitalized COVID-19 patients.
    Burnett CE; Okholm TLH; Tenvooren I; Marquez DM; Tamaki S; Sandoval PM; ; Calfee CS; Hendrickson CM; Kangelaris KN; Langelier CR; Krummel MF; Woodruff PG; Erle DJ; Ansel KM; Spitzer MH
    bioRxiv; 2022 Mar; ():. PubMed ID: 35313585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study.
    Hu Z; van der Ploeg K; Chakraborty S; Arunachalam PS; Mori DAM; Jacobson KB; Bonilla H; Parsonnet J; Andrews JR; Holubar M; Subramanian A; Khosla C; Maldonado Y; Hedlin H; de la Parte L; Press K; Ty M; Tan GS; Blish C; Takahashi S; Rodriguez-Barraquer I; Greenhouse B; Butte AJ; Singh U; Pulendran B; Wang TT; Jagannathan P
    Elife; 2022 Oct; 11():. PubMed ID: 36239699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
    Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
    Front Immunol; 2021; 12():691725. PubMed ID: 34248984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia.
    Kreutmair S; Unger S; Núñez NG; Ingelfinger F; Alberti C; De Feo D; Krishnarajah S; Kauffmann M; Friebel E; Babaei S; Gaborit B; Lutz M; Jurado NP; Malek NP; Goepel S; Rosenberger P; Häberle HA; Ayoub I; Al-Hajj S; Nilsson J; Claassen M; Liblau R; Martin-Blondel G; Bitzer M; Roquilly A; Becher B
    Immunity; 2021 Jul; 54(7):1578-1593.e5. PubMed ID: 34051147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.
    d'Ettorre G; Recchia G; Ridolfi M; Siccardi G; Pinacchio C; Innocenti GP; Santinelli L; Frasca F; Bitossi C; Ceccarelli G; Borrazzo C; Antonelli G; Scagnolari C; Mastroianni CM
    Medicine (Baltimore); 2020 Sep; 99(36):e21803. PubMed ID: 32899009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection.
    Wang Y; Wang X; Luu LDW; Li J; Cui X; Yao H; Chen S; Fu J; Wang L; Wang C; Yuan R; Cai Q; Huang X; Huang J; Li Z; Li S; Zhu X; Tai J
    J Med Virol; 2022 Nov; 94(11):5304-5324. PubMed ID: 35859327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).
    Agrati C; Sacchi A; Bordoni V; Cimini E; Notari S; Grassi G; Casetti R; Tartaglia E; Lalle E; D'Abramo A; Castilletti C; Marchioni L; Shi Y; Mariano A; Song JW; Zhang JY; Wang FS; Zhang C; Fimia GM; Capobianchi MR; Piacentini M; Antinori A; Nicastri E; Maeurer M; Zumla A; Ippolito G
    Cell Death Differ; 2020 Nov; 27(11):3196-3207. PubMed ID: 32514047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression patterns of purinergic ectoenzymes and the antioxidative role of IL-6 in hospitalized COVID-19 patient recovery.
    Mazzocco YL; Bergero G; Del Rosso S; Eberhardt N; Sola C; Saka HA; Villada SM; Bocco JL; Aoki MP
    Front Immunol; 2023; 14():1227873. PubMed ID: 37818368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive blood transcriptome analysis reveals cellular signaling networks activated by circulating glycocalyx components reflecting vascular injury in COVID-19.
    Borrmann M; Brandes F; Kirchner B; Klein M; Billaud JN; Reithmair M; Rehm M; Schelling G; Pfaffl MW; Meidert AS
    Front Immunol; 2023; 14():1129766. PubMed ID: 36776845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell immune profiling reveals long-term changes in myeloid cells and identifies a novel subset of CD9
    Pandori WJ; Padgett LE; Alimadadi A; Gutierrez NA; Araujo DJ; Huh CJ; Olingy CE; Dinh HQ; Wu R; Vijayanand P; Chee SJ; Ottensmeier CH; Hedrick CC
    J Leukoc Biol; 2022 Nov; 112(5):1053-1063. PubMed ID: 35866369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia.
    Chang CM; Feng PH; Wu TH; Alachkar H; Lee KY; Chang WC
    J Clin Immunol; 2021 Aug; 41(6):1131-1145. PubMed ID: 33950324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central and effector memory T cells in peripheral blood of patients with interstitial pneumonia: preliminary clues from a COVID-19 study.
    Bekbossynova M; Akhmaltdinova L; Dossybayeva K; Tauekelova A; Smagulova Z; Tsechoeva T; Turebayeva G; Sailybayeva A; Kalila Z; Mirashirova T; Muratov T; Poddighe D
    Respir Res; 2022 Oct; 23(1):278. PubMed ID: 36217141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients.
    Diray-Arce J; Fourati S; Doni Jayavelu N; Patel R; Maguire C; Chang AC; Dandekar R; Qi J; Lee BH; van Zalm P; Schroeder A; Chen E; Konstorum A; Brito A; Gygi JP; Kho A; Chen J; Pawar S; Gonzalez-Reiche AS; Hoch A; Milliren CE; Overton JA; Westendorf K; ; Cairns CB; Rouphael N; Bosinger SE; Kim-Schulze S; Krammer F; Rosen L; Grubaugh ND; van Bakel H; Wilson M; Rajan J; Steen H; Eckalbar W; Cotsapas C; Langelier CR; Levy O; Altman MC; Maecker H; Montgomery RR; Haddad EK; Sekaly RP; Esserman D; Ozonoff A; Becker PM; Augustine AD; Guan L; Peters B; Kleinstein SH
    Cell Rep Med; 2023 Jun; 4(6):101079. PubMed ID: 37327781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals.
    Prokop JW; Hartog NL; Chesla D; Faber W; Love CP; Karam R; Abualkheir N; Feldmann B; Teng L; McBride T; Leimanis ML; English BK; Holsworth A; Frisch A; Bauss J; Kalpage N; Derbedrossian A; Pinti RM; Hale N; Mills J; Eby A; VanSickle EA; Pageau SC; Shankar R; Chen B; Carcillo JA; Sanfilippo D; Olivero R; Bupp CP; Rajasekaran S
    Front Immunol; 2021; 12():694243. PubMed ID: 34335605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
    Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
    Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19.
    Mann ER; Menon M; Knight SB; Konkel JE; Jagger C; Shaw TN; Krishnan S; Rattray M; Ustianowski A; Bakerly ND; Dark P; Lord G; Simpson A; Felton T; Ho LP; ; Feldmann M; ; Grainger JR; Hussell T
    Sci Immunol; 2020 Sep; 5(51):. PubMed ID: 32943497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.